2,5-Dihydro-2,5-dioxo-N-[3-[3-(trifluoromethyl)-3H-diazirin-3-yl]phenyl]-1H-pyrrole-1-butanamide
CAS: 151077-62-2
Rif. 3D-FD102184
Dimensione non definita | Prezzo su richiesta |
Informazioni sul prodotto
- N-(m-(3-(Trifluoromethyl)-diazirin-3-yl)phenyl)-4-maleimidobutyramide
- Tdpmb
- 1H-Pyrrole-1-butanamide, 2,5-dihydro-2,5-dioxo-N-(3-(3-(trifluoromethyl)-3H-diazirin-3-yl)phenyl)-
- 4-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-N-{3-[3-(trifluoromethyl)-3H-diaziren-3-yl]phenyl}butanamide
2,5-Dihydro-2,5-dioxo-N-[3-[3-(trifluoromethyl)-3H-diazirin-3-yl]phenyl]-1H-pyrrole-1-butanamide (LZP) is an experimental drug that inhibits the growth of cancer cells. It has shown promising results in the treatment of bowel diseases and may be a candidate for normalizing bowel motility in patients with irritable bowel syndrome. LZP also has antiinflammatory effects, which may be due to its ability to inhibit cytokine production.
Proprietà chimiche
Richiesta tecnica su: 3D-FD102184 2,5-Dihydro-2,5-dioxo-N-[3-[3-(trifluoromethyl)-3H-diazirin-3-yl]phenyl]-1H-pyrrole-1-butanamide
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.